PF-23 GIDC Sanand II,Industrial Estate,

Ahmedabad - 382110,

Gujarat, India.

Phone : +91 70965 58558

Fax : NA

Email :  info@curisls.com

Website :  https://curisls.com

initial public issue of 21,50,000 equity shares of face value of (Rs) 10/- each of Curis Lifesciences Limited ("Curis" or the "company" or the "Issuer") for cash at a price of (Rs) [*]/- per equity share including a share premium of (Rs) [*]/- per equity share (the "Issue Price") aggregating to (Rs) [*] crores ("the Issue"), of which 1,08,000 equity shares of face value of (Rs) 10/- each for cash at a price of (Rs) [*]/- per equity share including a share premium of (Rs) [*]/- per equity share aggregating to (Rs) [*] crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 20,42,000 equity shares of face value of (Rs) 10/- each at a price of (Rs) [*]/- per equity share including a share premium of (Rs)[*]/- per equity share aggregating to (Rs) [*] crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.59% and 25.26%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is (Rs) 10/- each. Price band: Rs 120/- to Rs 128/- per equity share of face value (Rs) 10/- each. The floor price is 12 times of the face value and the cap price is 12.80 times of the face value of the equity shares. Bid can be made for a minimum of 2000 equity shares and in multiple of 1000 equity shares thereafter.

Minimum Application for shares in Nos : 2000   Further Multiples of : 1000